S. Arends

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

S. Kusunoki, L. Benedetti, C. Briani, 2021, Brain : a journal of neurology.

CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

H. Kramers, G. Marfia, T. Feasby, 2023, Neurology.

Predictive value of electroencephalography in anti-NMDA receptor encephalitis

P. S. Sillevis Smitt, D. Tavy, M. Titulaer, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

H. Kramers, G. Marfia, T. Feasby, 2023, Neurology.

Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome

Hester F. Lingsma, S. Kusunoki, M. Dimachkie, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values

John M Buermann, G. Marfia, H. Hartung, 2022, Clinical Neurophysiology.

Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study

A. A. van der Eijk, R. Huizinga, B. Jacobs, 2021, Journal of the peripheral nervous system : JPNS.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Hester F. Lingsma, E. Steyerberg, R. Hughes, 2021, The Lancet Neurology.

Second intravenous immunoglobulin dose in patients with Guillain-Barre syndrome with poor prognosis (

Hester F. Lingsma, C. Walgaard, A. J. Kooi, 2021 .